
On Wednesday, Coloplast publicized a study demonstrating a significant improvement in laryngectomy patients’ pulmonary symptoms when using the device Provox Life, the company reports in a press release.
The product was developed by Atos Medical, which was acquired by Coloplast last year and also funded the study.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app